LeMaitre Vascular Inc (LMAT)
Return on total capital
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 39,475 | 27,490 | 36,506 | 28,666 | 21,679 |
Long-term debt | US$ in thousands | — | — | 0 | 35,532 | 0 |
Total stockholders’ equity | US$ in thousands | 297,900 | 268,201 | 254,151 | 172,572 | 148,141 |
Return on total capital | 13.25% | 10.25% | 14.36% | 13.77% | 14.63% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $39,475K ÷ ($—K + $297,900K)
= 13.25%
Lemaitre Vascular Inc's return on total capital has shown a stable performance over the past five years, ranging from 11.16% to 14.33%. The company's ability to generate returns on its total capital has been relatively consistent, with a slight increase in 2023 compared to the previous year. This indicates that Lemaitre Vascular has been efficient in utilizing its total capital to generate profits for its stakeholders. The consistent performance in return on total capital is a positive sign of financial health and operational efficiency for the company.
Peer comparison
Dec 31, 2023
Company name
Symbol
Return on total capital
LeMaitre Vascular Inc
LMAT
13.25%
3M Company
MMM
-48.86%
Artivion Inc
AORT
0.63%
Baxter International Inc
BAX
37.30%
Becton Dickinson and Company
BDX
5.10%
Boston Scientific Corp
BSX
12.15%
DexCom Inc
DXCM
16.23%
Embecta Corp
EMBC
28.68%
Glaukos Corp
GKOS
-16.13%
Globus Medical
GMED
3.02%
Haemonetics Corporation
HAE
9.38%